Drug details
Tretten (catridecacog coagulation factor xiii a-subunit (recombinant))
type of
Tretten [(catridecacog) Coagulation Factor XIII A-Subunit (Recombinant)] is a recombinant human blood factor XIII-A2 homodimer composed of two factor XIII (FXIII) A-subunits used for routine prevention for bleeding in patients with congenital factor XIII A-subunit deficiency. Tretten is not for use in patients with congenital factor XIII B-subunit deficiency.
This drug may have the following side effects:
- itching
-
headache - pain in the extremities
- injection site pain
- increase in fibrin D dimer levels
- arthritis
- joint pain or
- skin redness.